Amoaku, W M
Article History
First Online: 16 June 2017
Competing interests
: WMA is a consultant for Alimera, Allergan Inc., Bayer, Novartis, Pfizer, Roche, Santen, and Thrombogenics, and has undertaken research sponsored by Allergan, Novartis, and Pfizer. He has received speaker fees and travel grants from Allergan, Bausch and Lomb, Bayer, Novartis and Pfizer.